Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
CASH FLOWS – OPERATING ACTIVITIES    
Net loss $ (7,659) $ (17,327)
Adjustments required to reconcile cash flows used in operating activities:    
Depreciation 236 229
Stock-based compensation 659 177
Finance income, net (53) (456)
Revaluation of contingent consideration 2 (2)
Loss (income) from change in fair value of warrants (914) 8,010
Private Placement Warrants issuance cost 732
Loss from sale and disposal of fixed assets, net 57
Changes in operating assets and liabilities:    
Other current assets 242 562
Trade accounts payable (212) (1,775)
Other accounts payable (1,076) (122)
Net change in operating leases 6 (1,384)
Net cash used in operating activities (8,712) (11,356)
CASH FLOWS – INVESTING ACTIVITIES    
Cash and restricted cash acquired from the APT acquisition 663
Proceeds from sale of property and equipment 51
Net cash provided by investing activities 51 663
CASH FLOWS – FINANCING ACTIVITIES    
Issuance of Common Stock under February 2025 SPA 996
February 2025 SPA issuance costs (87)
Issuance of Common Warrants under February 2025 SPA 4,531
Issuance of Common Stock under Inducement Letter Agreements 6,473  
Issuance of Private Placement Warrants under March 2024 PIPE 28,745
Issuance of Redeemable Convertible Preferred Shares under March 2024 PIPE 21,269
March 2024 PIPE issuance costs (316)
Pre-Funded Warrants exercise 5
Issuance of Common Stock under Open Market Sales Agreement, net of issuance costs 19
Repayment of long-term debt (10,747)
Net cash provided by financing activities 11,913 38,975
Increase in cash and cash equivalents and restricted cash 3,252 28,282
Effect of exchange rate changes on cash and cash equivalents and restricted cash 3 (31)
Cash and cash equivalents and restricted cash at the beginning of the period 17,975 15,864
Cash and cash equivalents and restricted cash at the end of the period 21,230 44,115
RECONCILIATION OF AMOUNTS ON CONSOLIDATED BALANCE SHEETS    
Cash and cash equivalents 20,116 43,007
Restricted cash 1,114 1,108
Total cash and cash equivalents and restricted cash 21,230 44,115
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash paid for interest 5 1,419
Taxes paid 1 3
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
February 2025 SPA issuance costs included in accounts payable 31
Property and equipment purchases included in accounts payable and Trade payable 17
March 2024 PIPE Issuance cost 1,826
Issuance of Common Stock under the APT acquisition 3,041
Issuance of Redeemable Convertible Preferred Shares under the APT acquisition 12,610
Issuance of Merger Warrants under the APT acquisition 200
Issuance cost from the APT acquisition $ 62